The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Medtronic PLC

NYSE: MDT
Last

(U.S.) $74.46

Today's change-1.74 -2.28%
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.
 

Medtronic PLC

NYSE: MDT
Last

(U.S.) $74.46

Today's change-1.74 -2.28%
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.

Medtronic PLC crosses below 200-day moving average

Medtronic PLC closed sharply lower Friday, dropping (U.S.)$1.74 or 2.28% to (U.S.)$74.46 and crossing below its 200-day moving average. Over the last five days, shares have lost 1.92% and are down 3.20% for the last year to date. This security has outperformed the S&P 500 by 7.71% during the last year.

Key company metrics

  • Open(U.S.) $76.04
  • Previous close(U.S.) $76.20
  • High(U.S.) $76.14
  • Low(U.S.) $74.09
  • Bid / Ask-- / --
  • YTD % change-3.20%
  • Volume4,667,311
  • Average volume (10-day)6,232,652
  • Average volume (1-month)5,842,334
  • Average volume (3-month)6,014,101
  • 52-week range(U.S.) $55.54 to (U.S.) $79.50
  • Beta1.01
  • Trailing P/E38.88×
  • P/E 1 year forward17.01×
  • Forward PEG2.49×
  • Indicated annual dividend(U.S.) $1.52
  • Dividend yield2.04%
  • Trailing EPS(U.S.) $1.92
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+8.92%

Based on its net profit margin of 8.92%, Medtronic PLC is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.08%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution

Latest Press Releases

    No Press Release Results.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedOct 30, 201510/30/2015Jul 31, 201507/31/2015Apr 24, 201504/24/2015Jan 23, 201501/23/2015
Revenue7,0587,2747,3044,318
Total other revenue--------
Total revenue7,0587,2747,3044,318
Gross profit4,8764,8184,3703,190
Total cost of revenue2,1822,4562,9341,128
Total operating expense5,7586,1436,9232,890
Selling / general / administrative2,3432,4492,4041,487
Research & development545558528373
Depreciation / amortization48348146889
Interest expense (income), net operating--------
Unusual expense (income)148138617-58
Other operating expenses, total6141-28-129
Operating income1,3001,1313811,428
Interest income (expense), net non-operating-324-306-299-176
Gain (loss) on sale of assets--------
Other--------
Income before tax1,0839401871,194
Income after tax520820-1977
Income tax, total563120188217
Net income520820-1977
Total adjustments to net income--------
Net income before extra. items520820-1977
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items520820-1977
Inc. avail. to common incl. extra. items520820-1977
Diluted net income520820-1977
Dilution adjustment------0
Diluted weighted average shares1,4291,4361,424996
Diluted EPS excluding extraordinary itemsvalue per share0.360.570.000.98
Dividends per sharevalue per share0.380.380.310.31
Diluted normalized EPSvalue per share0.410.650.280.96